HST Global, Inc. (HSTC.OB) Announces Medical Reimbursement Initiative
HST Global, Inc., an integrated biotechnology health and wellness company, announced this morning that it has launched an initiative with EBITDA Capital, LLC to pursue medical reimbursements for its treatments. HST Global, Inc. has launched this new initiative in view of the recent changes made to the federally funded Medicare Programs. The Company has asked EBITDA Capital, LLC and its Political Affiliates to initiate a dialogue with the proper federal agencies so that their treatments for fourth stage cancer are included in Medicare payment schedules. Mr. Chet Noblett, Managing General Partner, and his team at EBITDA Capital have already established…